197 related articles for article (PubMed ID: 27584082)
1. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.
Bassi DE; Zhang J; Renner C; Klein-Szanto AJ
Mol Carcinog; 2017 Mar; 56(3):1182-1188. PubMed ID: 27584082
[TBL] [Abstract][Full Text] [Related]
2. Proprotein convertase inhibition: Paralyzing the cell's master switches.
Klein-Szanto AJ; Bassi DE
Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
[TBL] [Abstract][Full Text] [Related]
3. Proprotein convertase inhibition promotes ciliated cell differentiation - a potential mechanism for the inhibition of Notch1 signalling by decanoyl-RVKR-chloromethylketone.
Lee SN; Choi IS; Kim HJ; Yang EJ; Min HJ; Yoon JH
J Tissue Eng Regen Med; 2017 Sep; 11(9):2667-2680. PubMed ID: 27878968
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer.
Page RE; Klein-Szanto AJ; Litwin S; Nicolas E; Al-Jumaily R; Alexander P; Godwin AK; Ross EA; Schilder RJ; Bassi DE
Cell Oncol; 2007; 29(4):289-99. PubMed ID: 17641413
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression.
de Cicco RL; Bassi DE; Benavides F; Conti CJ; Klein-Szanto AJ
Mol Carcinog; 2007 Aug; 46(8):654-9. PubMed ID: 17440928
[TBL] [Abstract][Full Text] [Related]
6. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
[TBL] [Abstract][Full Text] [Related]
7. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
[TBL] [Abstract][Full Text] [Related]
8. Polyphenols with indirect proprotein convertase inhibitory activity.
Zhu J; Van de Ven W; Vermorken A
Int J Oncol; 2013 Sep; 43(3):947-55. PubMed ID: 23835774
[TBL] [Abstract][Full Text] [Related]
9. Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7.
Scamuffa N; Basak A; Lalou C; Wargnier A; Marcinkiewicz J; Siegfried G; Chrétien M; Calvo F; Seidah NG; Khatib AM
Gut; 2008 Nov; 57(11):1573-82. PubMed ID: 18664504
[TBL] [Abstract][Full Text] [Related]
10. Ectopically expressed pro-group X secretory phospholipase A2 is proteolytically activated in mouse adrenal cells by furin-like proprotein convertases: implications for the regulation of adrenal steroidogenesis.
Layne JD; Shridas P; Webb NR
J Biol Chem; 2015 Mar; 290(12):7851-60. PubMed ID: 25623068
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of FURIN by prostaglandin-endoperoxide synthase 2 in lung epithelial NCI-H292 cells.
Brant KA; Leikauf GD
Mol Carcinog; 2014 Mar; 53(3):192-200. PubMed ID: 23065687
[TBL] [Abstract][Full Text] [Related]
12. The Proteolytic Regulation of Virus Cell Entry by Furin and Other Proprotein Convertases.
Izaguirre G
Viruses; 2019 Sep; 11(9):. PubMed ID: 31505793
[TBL] [Abstract][Full Text] [Related]
13. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Bassi DE; Mahloogi H; Klein-Szanto AJ
Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
[TBL] [Abstract][Full Text] [Related]
14. Secreted cysteine-rich FGF receptor derives from posttranslational processing by furin-like prohormone convertases.
Antoine M; Köhl R; Tag CG; Gressner AM; Hellerbrand C; Kiefer P
Biochem Biophys Res Commun; 2009 May; 382(2):359-64. PubMed ID: 19285038
[TBL] [Abstract][Full Text] [Related]
15. The proprotein convertase furin in tumour progression.
Jaaks P; Bernasconi M
Int J Cancer; 2017 Aug; 141(4):654-663. PubMed ID: 28369813
[TBL] [Abstract][Full Text] [Related]
16. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells.
Bassi DE; Mahloogi H; Lopez De Cicco R; Klein-Szanto A
Am J Pathol; 2003 Feb; 162(2):439-47. PubMed ID: 12547702
[TBL] [Abstract][Full Text] [Related]
17. Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1.
Lapierre M; Siegfried G; Scamuffa N; Bontemps Y; Calvo F; Seidah NG; Khatib AM
Cancer Res; 2007 Oct; 67(19):9030-4. PubMed ID: 17909005
[TBL] [Abstract][Full Text] [Related]
18. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
[TBL] [Abstract][Full Text] [Related]
19. Enzymic characterization in vitro of recombinant proprotein convertase PC4.
Basak A; Touré BB; Lazure C; Mbikay M; Chrétien M; Seidah NG
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):29-37. PubMed ID: 10493908
[TBL] [Abstract][Full Text] [Related]
20. Transgenic overexpression of the proprotein convertase furin enhances skin tumor growth.
Fu J; Bassi DE; Zhang J; Li T; Nicolas E; Klein-Szanto AJ
Neoplasia; 2012 Apr; 14(4):271-82. PubMed ID: 22577343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
